^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
DecisionDx®-UMSeq

Type:
Laboratory Developed Test
Related tests:

Details

Evidence
News
The DecisionDx-UMSeq test is a 7-gene panel that uses next-generation sequencing (NGS) to identify somatic mutations relevant to UM. The test includes hotspot mutations in the genes GNAQ, GNA11, CYSLTR2, PLCB4, and SF3B1, mutations in exons 1-2 of EIF1AX, and all coding exons of the BAP1 gene.
Cancer:
Uveal Melanoma
Gene:
BAP1 (BRCA1 Associated Protein 1), CYSLTR2 (Cysteinyl Leukotriene Receptor 2), EIF1AX (Eukaryotic Translation Initiation Factor 1A X-Linked), GNA11 (G Protein Subunit Alpha 11), GNAQ (G Protein Subunit Alpha Q), Other genes
See More ...
Method:
Next-Generation Sequencing